Type-1 diabetes accounts for 5%10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.
This report contains market size and forecasts of Type-1 Diabetes Treatment in Global, including the following market information:
- Global Type-1 Diabetes Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Type-1 Diabetes Treatment market was valued at 5165.4 million in 2021 and is projected to reach US$ 6938.7 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid-Acting Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Type-1 Diabetes Treatment include Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Type-1 Diabetes Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type-1 Diabetes Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, by Type, 2021 (%)
- Rapid-Acting Insulin
- Short-Acting Insulin
- Others
Global Type-1 Diabetes Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals & Clinics
- Academic & Research Institutes
Global Type-1 Diabetes Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Type-1 Diabetes Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Type-1 Diabetes Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Type-1 Diabetes Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astellas Pharma
- Merck
- Eli Lilly
- Novo Nordisk
- Sanofi
- AstraZeneca
- Boehringer Ingelheim GmbH
- Novartis
- Pfizer Inc.
- Abbott Laboratories
- Mannkind Corporation
- Braun Melsungen AG
- Macrogenics, Inc.
